LeMaitre Vascular to Present at Five Investor Conferences in March

Event summary

  • LeMaitre Vascular will participate in five investor conferences in March 2026.
  • Presentations scheduled for March 10, 11, and 17, with meetings on March 12 and 22-24.
  • Management will present at Leerink Partners, Citizens Life Sciences, and KeyBanc Capital Markets conferences.
  • 1x1 meetings planned at Barclays and ROTH conferences.
  • LeMaitre focuses on peripheral vascular disease treatments, serving vascular surgeons globally.

The big picture

LeMaitre Vascular's participation in multiple investor conferences underscores its focus on engaging with the financial community amid a competitive medical devices sector. The company's emphasis on peripheral vascular disease treatments aligns with global healthcare trends prioritizing vascular health innovations. These conferences provide a platform for LeMaitre to articulate its strategic vision and address investor concerns about market dynamics and growth prospects.

What we're watching

Strategic Messaging
How LeMaitre's presentations will emphasize growth in peripheral vascular disease treatments.
Investor Sentiment
Whether the conferences will shift market perception of LeMaitre's competitive positioning.
Operational Updates
The pace at which LeMaitre introduces new products or expands its market reach.